Microcarriers Market Size, Share & Trends Analysis Report By Consumable (Media & Reagents, Microcarrier Beads), By Application (Biopharmaceutical Production, Regenerative Medicine), By End Use, By Region, And Segment Forecasts, 2026 - 2033

Publisher Grand View Research

Published Dec 17, 2025

Length 120 Pages

SKU # GV20723844

Description

Microcarriers Market Summary

The global microcarriers market size was estimated at USD 2.13 billion in 2025 and is projected to reach USD 4.89 billion by 2033, growing at a CAGR of 11.18% from 2026 to 2033. The growth of the microcarriers industry is attributed to the high demand for cell-based vaccines & therapeutics, the increasing incidence of various diseases & disorders such as diabetes, cancer, rheumatoid arthritis, hemophilia, and others, huge investments for the development of innovative therapies, and consistent technological advancements in cell biology research.

For instance, in May 2024, Sartorius and Sanofi partnered to develop and commercialize a platform that streamlines and optimizes downstream bioprocessing operations, enhancing efficiency and productivity in the production of biopharmaceuticals. This can lead to the development of more sophisticated microcarrier-based bioprocessing technologies.

Global Microcarriers Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global microcarriers market report based on the consumable, application, end use, and region:

Consumable Outlook (Revenue, USD Million, 2021 - 2033)
Media & Reagents
Microcarrier Beads
Collagen Coated Beads
Cationic Beads
Protein Coated Beads
Untreated Beads
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Biopharmaceutical Production
Vaccine Production
Therapeutic Production
Regenerative Medicine
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations & Contract Manufacturing Organizations
Academic & Research Institutes
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation and Scope; 1.2. Research Methodology; 1.3. Information Procurement; 1.3.1. Purchased Database; 1.3.2. GVR’s Internal Database; 1.3.3. Secondary Sources; 1.3.4. Primary Research; 1.4. Information/Data Analysis; 1.5. Market Formulation & Visualization; 1.6. Data Validation & Publishing; 1.7. Model Details; 1.7.1. Model 1 Analysis; 1.7.2. Model 2 Analysis; 1.7.3. Model 3 Analysis; 1.8. List of Secondary Sources
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.3. Competitive Insights
Chapter 3. Companion Animal Osteoarthritis Market Variable Trends & Scope: 3.1. Market Lineage Outlook; 3.1.1. Parent Market; 3.1.2. Ancillary Market; 3.2. Market Dynamics; 3.2.1. Market Driver Analysis; 3.2.1.1. Advancements in Treatment for Pets; 3.2.1.2. Increasing Humanization of Pets & Expenditure on Pets; 3.2.1.3. Support Programs & Initiatives; 3.2.1.4. Changing Pet Demographics Globally; 3.2.2. Market Restraint Analysis; 3.2.2.1. Adverse Drug Reactions (ADR) in Treatments; 3.2.2.2. High Treatment Costs; 3.2.2.3. Complex Regulation Requirements; 3.2.3. Market Opportunity Analysis; 3.2.4. Market Challenge Analysis; 3.3. Companion Animal Osteoarthritis Market Analysis Tools; 3.3.1. Porter’s Five Forces Analysis; 3.3.2. PESTEL by SWOT Analysis; 3.4. Estimated Animal Population, by Key Species, by Key Countries, 2021-2024; 3.5. Product Pipeline Analysis
Chapter 4. Companion Animal Osteoarthritis Market: Product Estimates & Trend Analysis: 4.1. Segment Dashboard; 4.2. Companion Animal Osteoarthritis Market: Product Movement Analysis; 4.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million); 4.4. Biologics; 4.4.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.4.2. Stem Cells; 4.4.2.1. Stem Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.4.3. Platelet-Rich Plasma (PRP); 4.4.3.1. Platelet-Rich Plasma (PRP) Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.4.4. Monoclonal Antibodies (mAb); 4.4.4.1. Monoclonal Antibodies (mAb) Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.4.5. Other Biologics; 4.4.5.1. Other Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.5. Viscosupplements; 4.5.1. Viscosupplements Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.6. Pharmaceuticals; 4.6.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.6.2. Steroids; 4.6.2.1. Steroids Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.6.3. NSAIDs; 4.6.3.1. NSAIDs Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.6.4. Others; 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.7. Nutritional Supplements; 4.7.1. Nutritional Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.7.2. Chondroitin; 4.7.2.1. Chondroitin Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.7.3. Glucosamine; 4.7.3.1. Glucosamine Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.7.4. Methylsulfonylmethane (MSM); 4.7.4.1. Methylsulfonylmethane (MSM) Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.7.5. Hyaluronic Acid (HA); 4.7.5.1. Hyaluronic Acid (HA) Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.7.6. Omega-3 Fatty Acids; 4.7.6.1. Omega-3 Fatty Acids Market Estimates and Forecasts, 2021 - 2033 (USD Million); 4.7.7. Others; 4.7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Companion Animal Osteoarthritis Market: Animal Estimates & Trend Analysis: 5.1. Segment Dashboard; 5.2. Companion Animal Osteoarthritis Market: Animal Movement Analysis; 5.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million); 5.4. Canine; 5.4.1. Canine Market Estimates and Forecasts, 2021 - 2033 (USD Million); 5.5. Feline; 5.5.1. Feline Market Estimates and Forecasts, 2021 - 2033 (USD Million); 5.6. Equine; 5.6.1. Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Companion Animal Osteoarthritis Market: Route of Administration Estimates & Trend Analysis: 6.1. Segment Dashboard; 6.2. Companion Animal Osteoarthritis Market: By Route of Administration Movement Analysis; 6.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by route of administration, 2021 to 2033 (USD Million); 6.4. Oral; 6.4.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million); 6.5. Injectable; 6.5.1. Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million); 6.5.2. Intra-muscular; 6.5.2.1. Intra-muscular Market Estimates and Forecasts, 2021 - 2033 (USD Million); 6.5.3. Intra-articular; 6.5.3.1. Intra-articular Market Estimates and Forecasts, 2021 - 2033 (USD Million); 6.5.4. Other Injectable; 6.5.4.1. Other Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million); 6.6. Others; 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Companion Animal Osteoarthritis Market: By Distribution Channel Estimates & Trend Analysis: 7.1. Segment Dashboard; 7.2. Companion Animal Osteoarthritis Market: By Distribution Channel Movement Analysis; 7.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by distribution channel, 2021 to 2033 (USD Million); 7.4. Veterinary Hospitals/Clinics; 7.4.1. Veterinary Hospitals/Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5. E-commerce; 7.5.1. E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6. Others; 7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Companion Animal Osteoarthritis Market: Regional Estimates & Trend Analysis: 8.1. Regional Dashboard; 8.2. Companion Animal Osteoarthritis Market Share, By Region, 2025 & 2033 (USD Million); 8.3. Regional Outlook; 8.4. North America; 8.4.1. North America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.4.2. U.S.; 8.4.2.1. Key Country Dynamics; 8.4.2.2. Competitive Scenario; 8.4.2.3. Regulatory Framework; 8.4.2.4. U.S. Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.4.3. Canada; 8.4.3.1. Key Country Dynamics; 8.4.3.2. Competitive Scenario; 8.4.3.3. Regulatory Framework; 8.4.3.4. Canada Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.4.4. Mexico; 8.4.4.1. Key Country Dynamics; 8.4.4.2. Competitive Scenario; 8.4.4.3. Regulatory Framework; 8.4.4.4. Mexico Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5. Europe; 8.5.1. Europe Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5.2. UK; 8.5.2.1. Key Country Dynamics; 8.5.2.2. Competitive Scenario; 8.5.2.3. Regulatory Framework; 8.5.2.4. UK Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5.3. Germany; 8.5.3.1. Key Country Dynamics; 8.5.3.2. Competitive Scenario; 8.5.3.3. Regulatory Framework; 8.5.3.4. Germany Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5.4. France; 8.5.4.1. Key Country Dynamics; 8.5.4.2. Competitive Scenario; 8.5.4.3. Regulatory Framework; 8.5.4.4. France Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5.5. Italy; 8.5.5.1. Key Country Dynamics; 8.5.5.2. Competitive Scenario; 8.5.5.3. Regulatory Framework; 8.5.5.4. Italy Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5.6. Spain; 8.5.6.1. Key Country Dynamics; 8.5.6.2. Competitive Scenario; 8.5.6.3. Regulatory Framework; 8.5.6.4. Spain Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5.7. Denmark; 8.5.7.1. Key Country Dynamics; 8.5.7.2. Competitive Scenario; 8.5.7.3. Regulatory Framework; 8.5.7.4. Denmark Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5.8. Sweden; 8.5.8.1. Key Country Dynamics; 8.5.8.2. Competitive Scenario; 8.5.8.3. Regulatory Framework; 8.5.8.4. Sweden Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.5.9. Norway; 8.5.9.1. Key Country Dynamics; 8.5.9.2. Competitive Scenario; 8.5.9.3. Regulatory Framework; 8.5.9.4. Norway Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.6. Asia Pacific; 8.6.1. Asia Pacific Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.6.2. Japan; 8.6.2.1. Key Country Dynamics; 8.6.2.2. Competitive Scenario; 8.6.2.3. Regulatory Framework; 8.6.2.4. Japan Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.6.3. China; 8.6.3.1. Key Country Dynamics; 8.6.3.2. Competitive Scenario; 8.6.3.3. Regulatory Framework; 8.6.3.4. China Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.6.4. India; 8.6.4.1. Key Country Dynamics; 8.6.4.2. Competitive Scenario; 8.6.4.3. Regulatory Framework; 8.6.4.4. India Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.6.5. Australia; 8.6.5.1. Key Country Dynamics; 8.6.5.2. Competitive Scenario; 8.6.5.3. Regulatory Framework; 8.6.5.4. Australia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.6.6. South Korea; 8.6.6.1. Key Country Dynamics; 8.6.6.2. Competitive Scenario; 8.6.6.3. Regulatory Framework; 8.6.6.4. South Korea Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.6.7. Thailand; 8.6.7.1. Key Country Dynamics; 8.6.7.2. Competitive Scenario; 8.6.7.3. Regulatory Framework; 8.6.7.4. Thailand Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.7. Latin America; 8.7.1. Latin America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.7.2. Brazil; 8.7.2.1. Key Country Dynamics; 8.7.2.2. Competitive Scenario; 8.7.2.3. Regulatory Framework; 8.7.2.4. Brazil Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033; 8.7.3. Argentina; 8.7.3.1. Key Country Dynamics; 8.7.3.2. Competitive Scenario; 8.7.3.3. Regulatory Framework; 8.7.3.4. Argentina Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.8. Middle East & Africa; 8.8.1. Middle East & Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.8.2. South Africa; 8.8.2.1. Key Country Dynamics; 8.8.2.2. Competitive Scenario; 8.8.2.3. Regulatory Framework; 8.8.2.4. South Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.8.3. Saudi Arabia; 8.8.3.1. Key Country Dynamics; 8.8.3.2. Competitive Scenario; 8.8.3.3. Regulatory Framework; 8.8.3.4. Saudi Arabia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.8.4. UAE; 8.8.4.1. Key Country Dynamics; 8.8.4.2. UAE Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million); 8.8.5. Kuwait; 8.8.5.1. Key Country Dynamics; 8.8.5.2. Competitive Scenario; 8.8.5.3. Regulatory Framework; 8.8.5.4. Kuwait Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape: 9.1. Market Participant Categorization; 9.2. Company Market Position Analysis/ Heap Map Analysis; 9.3. Company Profiles; 9.3.1. Zoetis; 9.3.1.1. Participant’s Overview; 9.3.1.2. Financial Performance; 9.3.1.3. Product Benchmarking; 9.3.1.4. Strategic Initiatives; 9.3.2. Boehringer Ingelheim; 9.3.2.1. Participant’s Overview; 9.3.2.2. Financial Performance; 9.3.2.3. Product Benchmarking; 9.3.2.4. Strategic Initiatives; 9.3.3. Elanco Animal Health; 9.3.3.1. Participant’s Overview; 9.3.3.2. Financial Performance; 9.3.3.3. Product Benchmarking; 9.3.3.4. Strategic Initiatives; 9.3.4. American Regent, Inc.; 9.3.4.1. Participant’s Overview; 9.3.4.2. Financial Performance; 9.3.4.3. Product Benchmarking; 9.3.4.4. Strategic Initiatives; 9.3.5. Merck Animal Health (Merck & Co. Inc); 9.3.5.1. Participant’s Overview; 9.3.5.2. Financial Performance; 9.3.5.3. Product Benchmarking; 9.3.5.4. Strategic Initiatives; 9.3.6. Vetoquinol S.A.; 9.3.6.1. Participant’s Overview; 9.3.6.2. Financial Performance; 9.3.6.3. Product Benchmarking; 9.3.6.4. Strategic Initiatives; 9.3.7. Ceva Sante Animale; 9.3.7.1. Participant’s Overview; 9.3.7.2. Financial Performance; 9.3.7.3. Product Benchmarking; 9.3.7.4. Strategic Initiatives; 9.3.8. Virbac; 9.3.8.1. Participant’s Overview; 9.3.8.2. Financial Performance; 9.3.8.3. Product Benchmarking; 9.3.8.4. Strategic Initiatives; 9.3.9. Ardent Animal Health, Llc; 9.3.9.1. Participant’s Overview; 9.3.9.2. Financial Performance; 9.3.9.3. Product Benchmarking; 9.3.9.4. Strategic Initiatives; 9.3.10. PetVivo Holdings, Inc. (Spryng); 9.3.10.1. Participant’s Overview; 9.3.10.2. Financial Performance; 9.3.10.3. Product Benchmarking; 9.3.10.4. Strategic Initiatives; 9.3.11. VetStem Inc.; 9.3.11.1. Participant’s Overview; 9.3.11.2. Financial Performance; 9.3.11.3. Product Benchmarking; 9.3.11.4. Strategic Initiatives; 9.3.12. Enso Discoveries; 9.3.12.1. Participant’s Overview; 9.3.12.2. Financial Performance; 9.3.12.3. Product Benchmarking; 9.3.12.4. Strategic Initiatives; 9.3.13. Contura Vet US; 9.3.13.1. Participant’s Overview; 9.3.13.2. Financial Performance; 9.3.13.3. Product Benchmarking; 9.3.13.4. Strategic Initiatives; 9.3.14. T-Cyte Therapeutics; 9.3.14.1. Participant’s Overview; 9.3.14.2. Financial Performance; 9.3.14.3. Product Benchmarking; 9.3.14.4. Strategic Initiatives; 9.3.15. Medrego Llc.; 9.3.15.1. Participant’s Overview; 9.3.15.2. Financial Performance; 9.3.15.3. Product Benchmarking; 9.3.15.4. Strategic Initiatives; 9.3.16. Biogenesis Bago; 9.3.16.1. Participant’s Overview; 9.3.16.2. Financial Performance; 9.3.16.3. Product Benchmarking; 9.3.16.4. Strategic Initiatives; 9.4. List of Key Companies; 9.4.1. List of Manufacturers; 9.4.2. List of Distributors

Pricing

Currency Rates

Single User Email from Publisher $5,950
Multi User License Fulfilled by Publisher $6,950
Global Site License Email from Publisher $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now